A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...
A new blood test could improve survival rates for pancreatic cancer – a disease which often tends to be diagnosed at later ...
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal ...
A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...
When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
Ochsner's national study with The GRAIL Galleri® test is finding at least one hidden cancer a week in unsuspecting people. “I fully believe that in five, maybe 10 years, it will be routine to go to ...
Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood that could replace invasive biopsies and catch tumors when they are still ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage cancer ...
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society ...
Over a 1-year period, the mean number of any individual test per patient was seven tests, and the maximum number was 35 tests; the mean number of total tests per patient was 12 tests, and the maximum ...
Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center ...